![Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): A randomized placebo controlled clinical trial - eClinicalMedicine Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): A randomized placebo controlled clinical trial - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3a7f842d-3d5e-45df-bb55-6ff82add44dd/gr1_lrg.jpg)
Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): A randomized placebo controlled clinical trial - eClinicalMedicine
![Biomarker Clinical Trials in Lung Cancer: Design, Logistics, Challenges, and Practical Considerations - Journal of Thoracic Oncology Biomarker Clinical Trials in Lung Cancer: Design, Logistics, Challenges, and Practical Considerations - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8e1d7bdc-af75-4aae-b678-5666f5b8f6b6/gr1.jpg)
Biomarker Clinical Trials in Lung Cancer: Design, Logistics, Challenges, and Practical Considerations - Journal of Thoracic Oncology
![Rapper Common encourages lung cancer screenings, clinical trials for Black community in Bristol Myers-backed PSA | Fierce Pharma Rapper Common encourages lung cancer screenings, clinical trials for Black community in Bristol Myers-backed PSA | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1637076352/SU2C-BMS_Common_PSA_800x60021%20%28002%29.jpg?VersionId=0HwfkRZULOU7R0INV3TVBk51GjpDqMN_)
Rapper Common encourages lung cancer screenings, clinical trials for Black community in Bristol Myers-backed PSA | Fierce Pharma
![Clinical trials of tyrosine kinase inhibitors for lung cancer in China: a review | Journal of Hematology & Oncology | Full Text Clinical trials of tyrosine kinase inhibitors for lung cancer in China: a review | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-017-0514-z/MediaObjects/13045_2017_514_Fig1_HTML.gif)
Clinical trials of tyrosine kinase inhibitors for lung cancer in China: a review | Journal of Hematology & Oncology | Full Text
![Stage IV lung cancer survivor: Targeted therapy clinical trial is giving me another chance | MD Anderson Cancer Center Stage IV lung cancer survivor: Targeted therapy clinical trial is giving me another chance | MD Anderson Cancer Center](https://www.mdanderson.org/cancerwise/2018/01/stage-iv-lung-cancer-survivor--targeted-therapy-clinical-trial-is-giving-me-a-second-chance/_jcr_content/blog/adaptiveimage.resize.702.404.jpg)
Stage IV lung cancer survivor: Targeted therapy clinical trial is giving me another chance | MD Anderson Cancer Center
Penn Study Finds Solid-Tumor Cancer Patients Ineligible for Clinical Trials Receive Immunotherapy at Greater Rates Despite Lack of Benefits - Penn Medicine
![Analysis of time-to-treatment discontinuation of targeted therapy, immunotherapy, and chemotherapy in clinical trials of patients with non-small-cell lung cancer - Annals of Oncology Analysis of time-to-treatment discontinuation of targeted therapy, immunotherapy, and chemotherapy in clinical trials of patients with non-small-cell lung cancer - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bd2b12c5-3100-4c35-a512-e9e1e3344f78/gr1.jpg)
Analysis of time-to-treatment discontinuation of targeted therapy, immunotherapy, and chemotherapy in clinical trials of patients with non-small-cell lung cancer - Annals of Oncology
![Current clinical trials and patent update on lung cancer: a retrospective review | Lung Cancer Management Current clinical trials and patent update on lung cancer: a retrospective review | Lung Cancer Management](https://www.futuremedicine.com/cms/10.2217/lmt-2020-0029/asset/images/medium/figure2.gif)
Current clinical trials and patent update on lung cancer: a retrospective review | Lung Cancer Management
![The changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020 - The Lancet Regional Health – Western Pacific The changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020 - The Lancet Regional Health – Western Pacific](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/01e4a2e7-0f6f-4fa6-8019-8ff0f7624b10/gr2_lrg.jpg)
The changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020 - The Lancet Regional Health – Western Pacific
![Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials | Signal Transduction and Targeted Therapy Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-021-00557-9/MediaObjects/41392_2021_557_Fig1_HTML.png)
Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials | Signal Transduction and Targeted Therapy
![PL02.09 International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials - Journal of Thoracic Oncology PL02.09 International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/65a5883e-54cc-4c11-a710-6a26fcbffabf/fx1.jpg)